Rxcelerate

Rxcelerate company information, Employees & Contact Information

Explore related pages

Related company profiles:

RxCelerate Limited is an award-winning outsourced drug development company based in Cambridge (U.K) delivering complete preclinical programmes to our clients. We offer a comprehensive suite of services under one roof, including in silico modelling, medicinal chemistry, in vitro and preclinical capabilities, and project management. We pride ourselves on our ability to deliver innovative cutting-edge experimental solutions that save our clients time and money. Our flexible approach, commitment to quality, and ability to deliver results quickly make us the perfect partner for unlocking the true potential of your drug development journey. We are not just a company; we are a people-first organisation. We invest in and value our employees and have created an environment that encourages collaboration, innovation and personal growth. We foster a culture of inclusivity, where every team member’s voice is heard, and their ideas are valued. Connect with us to be part of our exciting journey!

Company Details

Employees
69
Founded
-
Address
Babraham Research Campus, Cambridge,cb22 3at,united Kingdom
Email
in****@****ate.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
CAMBRIDGE
Looking for a particular Rxcelerate employee's phone or email?

Rxcelerate Questions

News

Shift Bioscience Announces Key Appointments to Advance Rejuvenation Therapeutics Pipeline - BioSpace

Shift Bioscience Announces Key Appointments to Advance Rejuvenation Therapeutics Pipeline BioSpace

RxCelerate assembles SAB for its Biologics Discovery Unit - Business Weekly

RxCelerate assembles SAB for its Biologics Discovery Unit Business Weekly

PlaqueTec and RxCelerate Collaborate on Early Phase Drug Discovery for Coronary Artery Disease - Technology Networks

PlaqueTec and RxCelerate Collaborate on Early Phase Drug Discovery for Coronary Artery Disease Technology Networks

Rivus Pharmaceuticals Launches with $35 Million Series A Financing to Develop Novel Treatments for Cardio-Metabolic Diseases - PR Newswire

Rivus Pharmaceuticals Launches with $35 Million Series A Financing to Develop Novel Treatments for Cardio-Metabolic Diseases PR Newswire

RxCelerate acquires bioanalysis CRO Total Scientific - Fierce Biotech

RxCelerate acquires bioanalysis CRO Total Scientific Fierce Biotech

RxCelerate acquires Methuselah Health – launches “world-beating” proteomics service - Longevity.Technology

RxCelerate acquires Methuselah Health – launches “world-beating” proteomics service Longevity.Technology

From miner’s daughter to leading biotech boss - The Times

From miner’s daughter to leading biotech boss The Times

Haverford Man Named Director of B.Labs, a Unique Life Science Research Facility - DELCO.Today

Haverford Man Named Director of B.Labs, a Unique Life Science Research Facility DELCO.Today

Top Rxcelerate Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant